145 related articles for article (PubMed ID: 30254957)
21. Hysteroscopic management of retained products of conception: A single center observational study.
Alonso Pacheco L; Timmons D; Saad Naguib M; Carugno J
Facts Views Vis Obgyn; 2019 Sep; 11(3):217-222. PubMed ID: 32082527
[TBL] [Abstract][Full Text] [Related]
22. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception.
Ben-Ami I; Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R
Int J Gynaecol Obstet; 2014 Oct; 127(1):86-9. PubMed ID: 24997472
[TBL] [Abstract][Full Text] [Related]
23. Operative hysteroscopy in the minimally invasive management of interstitial pregnancy and interstitially retained products of conception: A case report and systematic literature review.
D'hoore E; D'hoore L; Van den Berghe S; Roets E; van Wessel S; Hamerlynck T
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():54-59. PubMed ID: 34428687
[TBL] [Abstract][Full Text] [Related]
24. Hysteroscopic tissue removal system (MyoSure) for the resection of polyps, sub-mucosal leiomyomas and retained products of conception in an out-patient setting: A single UK institution experience.
Georgiou D; Tranoulis A; Jackson TL
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():147-151. PubMed ID: 30388609
[TBL] [Abstract][Full Text] [Related]
25. Intercoat (Oxiplex/AP gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study.
Fuchs N; Smorgick N; Ben Ami I; Vaknin Z; Tovbin Y; Halperin R; Pansky M
J Minim Invasive Gynecol; 2014; 21(1):126-30. PubMed ID: 23954387
[TBL] [Abstract][Full Text] [Related]
26. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
[TBL] [Abstract][Full Text] [Related]
27. Enhanced myometrial vascularity: case presentation and review.
Woo J; Kahn B
Fertil Steril; 2021 Sep; 116(3):912-914. PubMed ID: 34217488
[TBL] [Abstract][Full Text] [Related]
28. The Intrauterine Bigatti Shaver System: An Alternative Option for Focal Retained Products of Conception.
Sutherland NSV; Rajesh H
Case Rep Obstet Gynecol; 2018; 2018():1536801. PubMed ID: 30584483
[TBL] [Abstract][Full Text] [Related]
29. Reproductive and Obstetric Outcomes After Hysteroscopic Removal of Retained Products of Conception.
van Wessel S; Coryn N; van Vliet H; Schoot B; Weyers S; Hamerlynck T
J Minim Invasive Gynecol; 2020; 27(4):840-846. PubMed ID: 31352066
[TBL] [Abstract][Full Text] [Related]
30. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
Tarasov M; Burke YZ; Stockheim D; Orvieto R; Cohen SB
Arch Gynecol Obstet; 2020 Dec; 302(6):1523-1528. PubMed ID: 32785781
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of Office-based Operative Hysteroscopy by a Tissue Removal System without Anesthesia.
Mor M; Kochav MG; Ezratty J; Dovev MN; Eisenberg N; Smorgick N
J Minim Invasive Gynecol; 2024 May; ():. PubMed ID: 38740128
[TBL] [Abstract][Full Text] [Related]
32. Uterine Arteriovenous Malformation Treated by Hysteroscopic Excision.
Kim TH; Kim NK; Kim SK; Lee JR; Jee BC; Kim YB; Kim SH
Gynecol Minim Invasive Ther; 2019; 8(3):132-134. PubMed ID: 31544025
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?
Yagur Y; Jurman L; Weitzner O; Arbib N; Markovitch O; Klein Z; Daykan Y; Schonman R
BMC Pregnancy Childbirth; 2023 Aug; 23(1):572. PubMed ID: 37563560
[TBL] [Abstract][Full Text] [Related]
34. Restoring Fertility of Patients with Severe Asherman's Syndrome in the Office Setting: A Step-by-Step Recipe for Success.
Di Spiezio-Sardo A; De Angelis MC; Dimitrios K; Manzi A; Zizolfi B; Carugno J; Isaacson K
J Minim Invasive Gynecol; 2023 May; 30(5):355-356. PubMed ID: 36764649
[TBL] [Abstract][Full Text] [Related]
35. Surgical and Reproductive Outcomes after Hysteroscopic Removal of Retained Products of Conception: A Systematic Review and Meta-analysis.
Vitale SG; Parry JP; Carugno J; Cholkeri-Singh A; Della Corte L; Cianci S; Schiattarella A; Riemma G; De Franciscis P
J Minim Invasive Gynecol; 2021 Feb; 28(2):204-217. PubMed ID: 33166659
[TBL] [Abstract][Full Text] [Related]
36. Clinical and imaging predictors of management in retained products of conception.
Kamaya A; Krishnarao PM; Nayak N; Jeffrey RB; Maturen KE
Abdom Radiol (NY); 2016 Dec; 41(12):2429-2434. PubMed ID: 27853850
[TBL] [Abstract][Full Text] [Related]
37. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
Bosteels J; van Wessel S; Weyers S; Broekmans FJ; D'Hooghe TM; Bongers MY; Mol BWJ
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009461. PubMed ID: 30521679
[TBL] [Abstract][Full Text] [Related]
38. Use of hysteroscopy in diagnosis and follow-up of acquired uterine enhanced myometrial vascularity.
Gingold JA; Bradley LD
Fertil Steril; 2020 Feb; 113(2):460-462. PubMed ID: 32106997
[TBL] [Abstract][Full Text] [Related]
39. Hysteroscopic management of molar pregnancy: A series of 36 cases.
de Codt M; Jadoul P; Luyckx M; Squifflet JL; Dolmans MM; Maillard C; Baurain JF; Marbaix E; Gerday A
Rare Tumors; 2023; 15():20363613231168767. PubMed ID: 37035475
[No Abstract] [Full Text] [Related]
40. Hysteroscopic Intrauterine Adhesiolysis Using a Blunt Spreading Dissection Technique With Double-action Forceps.
Huang H; Cheng C; Johnson G; Wang R; Xue M; Zhang A; Xu D; Guan X
J Minim Invasive Gynecol; 2018; 25(4):583-584. PubMed ID: 29038040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
